11 Nichols BE, Sheffield VC, Vandenburgh K, Drack AV, Kimura In the control of ocular infections, risk factors and public health interventions have been defined for trachoma. A new antibiotic azithromycin offers the hope of a systemic long acting chemotherapeutic agent to control chlamydial infection; and the correction of trichiasis within affected communities by paramedical workers has been reported to give successful results.7'9 In parts ofwest Africa onchocerciasis has been prevented by putting larvicides in rivers to control the Simulium fly vector. Ivermectin, a microfilaricide, given orally on an annual basis, reduces the community microfilaria load with a consequent decrease in the incidence of ocular disease,'0 and macrofilaricides which eliminate the adult worm, Onchocerca volvulus, are being field tested. There is therefore justified optimism that blindness from this disease can be prevented in the next decade.
Vitamin A deficiency, as well as being the main cause of childhood blindness, has been found to be an important cause of infant mortality."' Major nutrition and vitamin A supplementation programmes are being developed as part of child survival programmes which should also lead to a reduction in nutritional blindness.
If the causes of blindness are known, and the knowledge and technology to control blinding diseases have been developed, what are the reasons for the continuing rise in the number of people becoming blind? An increasing world population and improved life expectancy in developing countries are obvious factors, but there are other important reasons to be considered, particularly when one realises that at least 80% of all blindness is potentially avoidable.
Awareness
The first reason is lack of awareness. Many blind people with cataract living in poor areas of the developing world are not aware that they can be helped. Similarly, health care professionals may not be aware of the size of the problem and the need to mobilise resources to deal with avoidable blindness as a priority.
Accessibility
The second reason is the problem of accessibility. Blind patients may have limited or no access to the available specialised services because of geographic or social isolation. The majority of blind people live in Asia (20 million) or Africa (6 million). They are usually elderly people who will not travel more than 20 miles to see a specialist at a hospital.
In parts of Asia and, particularly, Africa there are few available specialists (India one ophthalmologist/100 000 population, Africa on average one ophthalmologist/i million population, compared with Europe at approximately 1/20000), and within a country there is often unequal distribution of specialist services, with a concentration in the larger cities and very limited services in rural areas.
Affordability
The third reason concerns affordability. The cost of medical care throughout the world continues to increase. The proportion of government funding spent on health in developing countries has increased very little over the past 25 years and, moreover, these same countries have become poorer in real terms. ' 
